Search Within

Advanced Practice Providers

  1. "Gastrointestinal Oncology Service"
Formats
  1. Meeting Abstract (72)
  2. Journal Article (59)
  3. Research Letter (2)
  4. Book Section (1)
  5. Editorial (1)
  6. Miscellaneous (1)
  7. Review (1)
Groups
  1. Department of Medicine (137)
  2. Gastrointestinal Oncology Service (137)
  3. Solid Tumor Oncology Division (137)
  4. Nursing (115)
  5. Center for Pancreatic Cancer Research (62)
  6. Survivorship Research (55)

More Groups

People
  1. Ellen Hollywood (37)
  2. Leonard Saltz (31)
  3. Armin Shahrokni (30)
  4. Diane Reidy (28)
  5. Andrew Epstein (27)
  6. Beatriz Korc-Grodzicki (26)

More People

Years
  1. 2025 (4)
  2. 2024 (4)
  3. 2023 (6)
  4. 2022 (9)
  5. 2021 (14)
  6. 2020 (13)

More Years

Publications
  1. Journal of Clinical Oncology (56)
  2. Journal of Pain and Symptom Management (8)
  3. JCO Oncology Practice (7)
  4. Journal of the American Geriatrics Society (5)
  5. Annals of Oncology (4)
  6. Cancer (4)

More Publications

Publishers
  1. American Society of Clinical Oncology (69)
  2. Elsevier Inc. (15)
  3. Wiley Blackwell (11)
  4. Oxford University Press (7)
  5. American Association for Cancer Research (5)
  6. Springer (4)

More Publishers

Results (137)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The effect of age on technology acceptance by cancer patients
    Meeting Abstract

    Shahrokni, A.; Pinheiro, N.; Mahmoudzadeh Pournaki, S.
    Journal of the American Geriatrics Society (2015)

    Fulltext@MSK | Save
  • Impact of weight loss on surgical outcomes in older abdominal cancer patients
    Meeting Abstract

    McMillan, S.; Korc-Grodzicki, B.; Shahrokni, A.
    Journal of the American Geriatrics Society (2015)

    Fulltext@MSK | Save
  • Survival, response duration, and activity by BRAF mutation (MT) status of nivolumab (NIVO, anti-PD-1, BMS-936558, ONO-4538) and ipilimumab (IPI) concurrent therapy in advanced melanoma (MEL)
    Meeting Abstract

    Sznol, M.; Kluger, H. M.; Callahan, M. K.; Postow, M. A.; Gordon, R. A.; Segal, N. H.; Rizvi, N. A.; Lesokhin, A. M.; Atkins, M. B.; Kirkwood, J. M.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Phase IB trial of cisplatin (C), gemcitabine (G), and veliparib (V) in patients with known or potential BRCA or PALB2-mutated pancreas adenocarcinoma (PC)
    Meeting Abstract

    O'Reilly, E. M.; Lowery, M. A.; Segal, M. F.; Smith, S. C.; Moore, M. J.; Kindler, H. L.; Golan, T.; Segal, A.; Salo-Mullen, E. E.; Hollywood, E.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Phase 1b study of R05137382/GC33 in combination with sorafenib in patients with advanced hepatocellular carcinoma (HCC) (NCT00976170)
    Meeting Abstract

    Abou-Alfa, G. K.; Yen, C. J.; Carrasquillo, J. A.; Hsu, C. H.; Gansukh, B.; Ma, J.; Hollywood, E.; Wan, P. J.; Shao, Y. Y.; Lin, Z. Z.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Survival, response duration, and activity by BRAF mutation (MT) status in a phase 1 trial of nivolumab (anti-PD-1, BMS-936558, ONO-4538) and ipilimumab (IPI) concurrent therapy in advanced melanoma (MEL)
    Meeting Abstract

    Kluger, H.; Sznol, M.; Callahan, M.; Postow, M.; Gordon, R.; Segal, N. H.; Rizvi, N.; Lesokhin, A.; Atkins, M. B.; Kirkwood, J.; more...
    Annals of Oncology (2014)

    Fulltext@MSK | Save
  • Neoadjuvant chemotherapy without routine use of radiation therapy for patients with locally advanced rectal cancer: A pilot trial
    Journal Article

    Schrag, D.; Weiser, M. R.; Goodman, K. A.; Gonen, M.; Hollywood, E.; Cercek, A.; Reidy-Lagunes, D. L.; Gollub, M. J.; Shia, J.; Guillem, J. G.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Safety and clinical activity of nivolumab (anti-PD-1, BMS-936558, ONO-4538) in combination with ipilimumab in patients (pts) with advanced melanoma (MEL)
    Meeting Abstract

    Wolchok, J. D.; Kluger, H. M.; Callahan, M. K.; Postow, M. A.; Gordon, R. A.; Segal, N. H.; Rizvi, N. A.; Lesokhin, A. M.; Reed, K.; Burke, M. M.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Randomized phase II study of gemcitabine (G), cisplatin (C) with or without veliparib (V) (arms A, B) and a phase II single-arm study of single-agent veliparib (arm C) in patients with BRCA or PALB2-mutated pancreas adenocarcinoma (PC)
    Meeting Abstract

    O'Reilly, E. M.; Lowery, M. A.; Yu, K. H.; Capanu, M.; Stadler, Z. K.; Epstein, A. S.; Golan, T.; Segal, A.; Segal, M.; Salo-Mullen, E. E.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Phase I study of LOR-253, a novel inducer of Kruppel-like factor 4, in patients with advanced solid tumors
    Meeting Abstract

    Cercek, A.; Wheler, J.; Weisberger, E.; Anderson, R.; Hollywood, E.; Zhou, S.; Murray, P.; Lee, Y.; Zinner, R.; Saltz, L.
    European Journal of Cancer (2013)

    Fulltext@MSK | Save